Brain Tumors

Brain Tumors: Overview and Management

Introduction to Brain Tumors

  • Definition: A brain tumor is an abnormal growth of cells in the brain or other parts of the central nervous system (CNS), which includes the spinal cord and cranial nerves.
  • Function of the Brain: The brain is crucial for controlling most bodily functions:
      - Awareness
      - Movements
      - Sensations
      - Thoughts
      - Speech
      - Memory
  • Impact of Tumors: Tumors can significantly impair the brain's ability to function properly, affecting the aforementioned bodily functions.

Incidence of Brain Tumors

  • Cancer Rank: Brain and other CNS tumors are classified as the fifth most common cancer.
  • Annual Diagnoses: Approximately 23,400 individuals are diagnosed annually with this condition.
  • Living with Diagnosis: Over 1 million people in the United States are currently living with a primary brain tumor diagnosis.
  • Malignancy Rate: Almost one-third (27.9%) of brain and CNS tumors are classified as malignant.
  • Childhood Diagnoses: These tumors are the most prevalent cancer type diagnosed in children aged 0–14 years.
  • Gender Trends: Incidence rates show that males are more frequently diagnosed than females.

Types of Brain Tumors

  • Primary Tumors:
      - Arise from brain tissue.
      - Common Types:
        - Meningiomas: Most prevalent type, usually benign.
        - Gliomas: Includes astrocytomas and glioblastomas.
  • Secondary Tumors (Metastatic):
      - These tumors originate from cancer spread.
      - Most Common Sources: Primarily metastasize from lung and breast cancers.
  • Key Point:
      - More than half of brain tumors are malignant; primary tumors rarely metastasize outside the CNS.

Common Tumor Locations

  • Meningioma:
      - Location: Membranes surrounding the brain/spinal cord.
      - Typically benign.
  • Gliomas:
      - Location: Brain and spinal cord tissue.
      - Usually malignant.
  • Pituitary Adenoma:
      - Location: Anterior pituitary.
      - Usually benign.
  • Vestibular Schwannoma:
      - Location: Vestibulocochlear nerve.
      - Usually benign and can affect hearing.
  • Medulloblastoma:
      - Location: Posterior fossa/spinal cord.
      - More common in children.

Clinical Manifestations

  • Headaches:
      - Often worse at night and described as dull and constant.
  • Seizures:
      - Commonly occur in gliomas and metastatic tumors.
  • Increased Intracranial Pressure (ICP) Symptoms:
      - Nausea and vomiting.
  • Neurological Deficits:
      - Weakness, sensory loss, aphasia (difficulty in communication), visual-spatial dysfunction.
  • Cognitive Changes:
      - Memory issues and alterations in personality/mood.
  • Hydrocephalus:
      - May occur due to obstruction of the ventricles.

Diagnostic Studies

  • CT Scan with Contrast:
      - Helps identify the location of lesions.
  • MRI:
      - Most sensitive imaging technique; effective in detecting small tumors.
  • PET Scans:
      - Provides better diagnostic information compared to CT scans.
  • Additional Studies:
      - MR spectroscopy, functional MRI (fMRI), single-photon emission computed tomography (SPECT).
  • Biopsy:
      - To assess tumor type and malignancy.
  • Blood Cancer Markers:
      - Looking for specific cancer antigens in the blood.

Surgical Management

  • Preference:
      - Surgery is the preferred treatment when feasible.
  • Complete Removal:
      - Common for meningiomas and oligodendrogliomas.
  • Partial Removal:
      - Often necessary for invasive gliomas and medulloblastomas.
  • Benefits of Surgery:
      - Reduces tumor mass, decreases ICP, alleviates symptoms, and potentially extends survival.
  • Techniques Used in Surgery:
      - Stereotactic surgery, computer-guided biopsy, and cortical mapping.

Chemotherapy & Targeted Therapy

  • Challenges:
      - Blood-brain barrier limits the effectiveness of many chemotherapeutic agents.
  • Effective Agents:
      - Nitrosoureas: Includes Carmustine and Lomustine.
      - Temozolomide (Temodar):
      - An oral agent capable of crossing the blood-brain barrier.
  • Direct Delivery Methods:
      - Gliadel Wafers: Implanted during surgery.
      - Intrathecal Administration: Via Ommaya reservoir.
  • Other Chemotherapeutic Agents:
      - Methotrexate and Procarbazine.
  • Radiation Techniques:
      - Stereotactic Radiosurgery: Delivers a high dose of precise radiation directly to the tumor.
      - Whole Brain Radiation Therapy: Used in certain cases.
  • Steroids:
      - Often utilized for reducing inflammation and managing symptoms.

Nursing Considerations

  • Neuro Examination: Regular assessments should be conducted.
  • Monitor for Seizures: Vital to manage potential seizure activity.
  • Signs/Symptoms of Elevated ICP:
      - Watch for changes indicating increased ICP.
  • Assess Self-Care Deficits: Determine if assistance is needed post-treatment.
  • Pain and Anxiety Management: Address both physical pain and emotional distress.
  • Referral to Hospice:
      - Considered when appropriate for end-of-life care.

Principles of Wellness/Health Maintenance Post-Treatment

  • Understanding of Disease and Treatment: Encourage patients and families to write down questions.
  • Seizure Awareness:
      - Discuss seizure medications and activities to avoid (driving, heights, deep water).
  • Protection During Chemotherapy:
      - Importance of up-to-date vaccinations, wearing masks in public, and practicing hand hygiene.
  • Nutrition: Emphasize the importance of adequate nutritional intake.

Sample Teaching Plan: Immediate Post-Operative Care After Cranial Surgery

  • Critical Safety Information:
  1. Signs/Symptoms to Report:
       - Severe headache
       - Vision changes
       - Confusion
       - Seizure activity
       - Excessive drowsiness or difficulty waking
       - Fever or drainage from incision
       - Weakness or numbness.
  2. Activity Restrictions and Safety:
       - Safe transfer techniques.
       - Fall prevention strategies.
       - Head elevation requirements.
       - Limitations on movement.
  3. Medication Management:
       - Prescribe and ensure safe administration of pain medications.
       - Administer anti-seizure medications as needed.
       - Instructions on tapering steroids if prescribed.
Teaching Methods:
  • Verbal Communication: Most effective for addressing patient questions and concerns.
  • Written Materials: Provide references for patient use.
  • Demonstration and Return Demonstration: Teach skills necessary for home care.
  • ICU/Special Care Unit Orientation: Familiarize patients with the environment and protocols.
Expected Outcomes:
  • With effective education, anticipate:
      - Reduced patient anxiety.
      - Improved satisfaction levels.
      - Better adherence to activity restrictions.
      - Fewer complications following surgery.
      - Realistic expectations regarding recovery.

Restorative Nursing Principles

  • Questioning Strategy:
      - Progress from general to specific questioning.
      - Open-Ended Questions: Start with broad inquiries to facilitate open communication.
      - Focused Questions: Narrow down to gather specific details.
      - Closed-Ended Questions: Use sparingly for the gathering of factual data.
      - Avoid Overquestioning: Too many questions can feel dehumanizing and hinder relationship-building.

Emerging Treatments

  • Fluorescence-Guided Surgery for Gliomas:
  • Methylene Blue:
      - Enhances cancer treatment through mitochondrial support and photodynamic therapy (PDT).
      - Benefits:
        - Increases tumor oxygenation.
        - Disrupts cancer cell metabolism by shifting energy production from glycolysis to oxidative phosphorylation.
        - Sensitizes tumors to radiation and chemotherapy.

References

  • Primary Texts:
      - Harding, M. M., Kwong, J., Roberts, D., Hagler, D., & Reinisch, C. (2020). Lewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems (11th ed.). Elsevier.
  • Guidelines:
      - Huntoon, K., Elder, J. B., Finger, G., Ormond, D. R., Redjal, N., Linskey, M. E., & Olson, J. J. (2025). CNS guideline for brain metastases: Update to emerging therapies. "Tumor Congress of Neurological Surgeons systematic review and evidence-based guidelines update for the role of emerging therapies in the management of patients with metastatic brain tumors." Neurosurgery, 96(6), 1172–1177.